$2.67
-0.05[-1.84%]
At close: Apr 22
$2.67
0[0.00%]
After Hours: 4:58PM EDT
Aytu BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aytu BioPharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | AYTU | Q3 | -$1.93 | -$0.64 | — | — | $22.73M | $17.35M | — | — | Get Alert |
02/14/2024 | PM | AYTU | Q2 | -$2.15 | -$0.25 | -$0.04 | 84.00% | $26.28M | $21.75M | $22.93M | 5.47% | Get Alert |
11/14/2023 | PM | AYTU | Q1 | -$1.20 | — | -$1.48 | — | $27.66M | $27.73M | $22.10M | -20.31% | Get Alert |
09/27/2023 | PM | AYTU | Q4 | -$9.80 | -$0.95 | -$0.59 | 37.89% | $27.45M | $27.69M | $30.73M | 10.99% | Get Alert |
05/11/2023 | PM | AYTU | Q3 | -$5.40 | -$0.63 | -$1.93 | -206.35% | $24.20M | $28.00M | $22.73M | -18.81% | Get Alert |
02/21/2023 | PM | AYTU | Q2 | -$8.80 | -$1.60 | -$2.15 | -34.38% | $23.13M | $26.40M | $26.28M | -0.46% | Get Alert |
11/14/2022 | PM | AYTU | Q1 | -$6.60 | -$3.60 | -$1.20 | 66.67% | $21.90M | $24.30M | $27.66M | 13.81% | Get Alert |
09/27/2022 | PM | AYTU | Q4 | -$16.20 | -$7.40 | -$9.80 | -32.43% | $23.48M | $25.50M | $27.45M | 7.64% | Get Alert |
05/16/2022 | PM | AYTU | Q3 | -$8.60 | -$8.20 | -$5.40 | 34.15% | $13.48M | $24.80M | $24.20M | -2.42% | Get Alert |
02/14/2022 | PM | AYTU | Q2 | -$14.40 | -$11.60 | -$8.80 | 24.14% | $15.15M | $27.20M | $23.13M | -14.98% | Get Alert |
11/15/2021 | PM | AYTU | Q1 | -$8.00 | -$9.80 | -$6.60 | 32.65% | $13.52M | $22.10M | $21.90M | -0.92% | Get Alert |
09/27/2021 | PM | AYTU | Q4 | -$4.00 | -$9.80 | -$16.20 | -65.31% | $14.86M | $20.90M | $23.48M | 12.35% | Get Alert |
05/17/2021 | PM | AYTU | Q3 | -$30.00 | -$6.20 | -$8.60 | -38.71% | $8.16M | $14.06M | $13.48M | -4.11% | Get Alert |
02/11/2021 | PM | AYTU | Q2 | -$62.00 | -$8.80 | -$14.00 | -59.09% | $3.17M | $12.25M | $15.15M | 23.65% | Get Alert |
11/12/2020 | PM | AYTU | Q1 | -$64.00 | -$10.00 | -$8.00 | 20.00% | $1.44M | $13.33M | $13.52M | 1.43% | Get Alert |
10/06/2020 | PM | AYTU | Q4 | -$260.00 | -$6.00 | -$4.00 | 33.33% | $1.72M | $11.24M | $14.86M | 32.22% | Get Alert |
05/14/2020 | PM | AYTU | Q3 | -$100.00 | -$44.00 | -$30.00 | 31.82% | $2.38M | $6.40M | $8.16M | 27.44% | Get Alert |
02/13/2020 | PM | AYTU | Q2 | -$144.00 | -$48.00 | -$62.00 | -29.17% | $1.79M | $2.74M | $3.17M | 15.88% | Get Alert |
11/14/2019 | PM | AYTU | Q1 | -$144.00 | -$60.00 | -$64.00 | -6.67% | $1.79M | $2.01M | $1.44M | -28.36% | Get Alert |
Aytu BioPharma (AYTU) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on February 14, 2024 for Q2.
The Actual EPS was $-0.04, which beat the estimate of $-0.25.
The Actual Revenue was $22.9M, which beat the estimate of $21.7M.
Browse earnings estimates, EPS, and revenue on all stocks.